Using magnetocardiography to identify heart attacks
Official title: Ultra-sensitive Magnetocardiography in the Accurate Identification of Myocardial Infarction
Run by Qilu Hospital of Shandong University · NCT05896826 · Data updated 2026-11-12
This study is testing if a new noninvasive heart scan method can help doctors better identify heart attacks in people with chest pain and healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 79 Years |
| Sex | All |
| Enrollment | 3841 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | October 31, 2025 |
| Study ends | December 1, 2026 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT05896826 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy individuals aged 18-79 with no history of cardiovascular disease or significant risk factors.
✕Probably not a fit
Patients with acute or chronic respiratory diseases, significant liver or kidney dysfunction, or other serious health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of magnetocardiography (MCG) as a noninvasive method for accurately detecting myocardial infarction. It will involve healthy volunteers and patients experiencing chest pain, who will undergo various diagnostic tests including electrocardiograms and cardiac imaging. The study seeks to develop precise analytical models for MCG to enhance the detection of heart attacks. By utilizing up-to-date examination instruments, the research aims to improve the accuracy of myocardial infarction diagnosis.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and noninvasive methods for diagnosing myocardial infarction, potentially improving patient outcomes.
How similar studies have gone: While magnetocardiography is a promising approach, this specific application is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
For healthy volunteers: Inclusion Criteria: 1. Age 18-79 years old; 2. No history of cardiovascular disease (coronary heart disease, structural heart disease, arrhythmia, heart failure, stroke, pulmonary embolism, aortic dissection, etc.), no cardiovascular risk factors (hypertension, diabetes, hyperlipidemia). For people over 65 years old, those with hypertension or hyperlipidemia, but with well-controlled blood pressure and lipid levels, taking no more than 2 drugs, and echocardiography showing no left ventricular hypertrophy, can be included; 3. The electrocardiogram is normal, and the cardiac ultrasound is basically normal in the past 1 year (mild valvular regurgitation can be included). 4. Sign the informed consent. Exclusion Criteria: 1. Those who with acute or chronic respiratory diseases; 2. Those who with obvious abnormality of liver or kidney function; 3. Those who with endocrine diseases such as abnormal thyroid function; 4. Those who with anemia or other blood diseases; 5. Those who with connective tissue diseases (lupus erythematosus, rheumatoid arthritis, dermatomyositis, polyarteritis nodosa, etc.); 6. Those who are obese (BMI\>30kg/cm2) or underweight (BMI\<18kg/cm2); 7. Those who with malignant tumors; 8. Those who with infectious diseases or infectious diseases; 9. Those who with trauma or physical disability; 10. Those who with psychological or mental illness such as depression; 11. Those who are professional athletes, pregnant or breastfeeding women, alcoholics; 12. Those who are unable to perform magnetocardiography examination due to claustrophobia, etc., or those who fail to receive magnetocardiography examination; 13. Due to various reasons such as allergy to contrast agents, metal implants in vivo that are prohibited from performing 1.5T MRI (such as prostheses or steel plates implanted in orthopaedics, uterine contraceptive device) and other reasons, those who cannot or fail to cooperate with the corresponding research requirements. For chest pain patients who will receive ECG, biomarkers, or non-invasive imaging examination: Inclusion Criteria: 1. Age 18-79 years old; 2. Those with chest pain symptoms, diagnosed or highly suspected by the attending doctor or above as stable angina pectoris (SA), unstable angina pectoris (UA), non-ST segment elevation myocardial infarction (NSTEMI), ST segment elevation myocardial infarction (STEMI), and plan to receive electrocardiogram, biomarkers (high-sensitivity cardiac troponin, etc), or non-invasive imaging (cardiac magnetic resonance or single-photon-emission tomography); 3. Sign the informed consent. Exclusion Criteria: 1. Patients with known structural heart disease such as cardiomyopathy and valvular disease; 2. Patients with arrhythmias such as atrial fibrillation, supraventricular tachycardia, and atrioventricular block that have not returned to normal; 3. History of other cardiovascular diseases such as pulmonary embolism and aortic dissection; 4. Patients with connective tissue diseases (lupus erythematosus, rheumatoid arthritis, dermatomyositis, polyarteritis nodosa, etc.) combined with cardiac complications; 5. Obvious abnormal thyroid function, severe anemia or other blood diseases and other diseases that obviously affect the circulating blood supply; 6. Obese (BMI\>30kg/cm2) or underweight (BMI\<18kg/cm2); 7. Patients with malignant tumors; 8. Professional athletes, pregnant or breastfeeding women, alcoholics; 9. Acute diseases or critical illnesses in other systems, such as acute or severe respiratory diseases, abnormal liver function or renal function, etc.; 10. Patients with infectious diseases or infectious diseases; 11. Those who are unable or fail to perform magnetocardiography due to claustrophobia, physical impairment, etc.; 12. Unable to or fail to cooperate with the corresponding research requirements.
Where it's running
-
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Principal investigator: Yuguo Chen, Dr — Qilu Hospital of Shandong University
- Study coordinator: Jiaojiao Pang, Dr.
- Email: jiaojiaopang@126.com
- Phone: 0086-0531-82165674
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating new cardiac biomarkers for diagnosing acute coronary syndrome
This study is testing new blood markers to see if they can help doctors better diagnose acute coronary syndrome in patients who might be having a heart attack.
-
ML-based diagnosis of blocked arteries in patients with a left bundle branch block
Doctors are testing a machine learning tool that uses digital ECGs to see if a blocked coronary artery is present in patients with a left bundle branch block.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
AI-assisted interpretation of chest pain CT in the emergency department
A pragmatic randomized trial tests whether an AI tool (Angiomics) helps emergency physicians interpret coronary CT angiography in adults with acute chest pain.
-
Understanding sex hormones and inflammation in heart disease
This study looks at how sex hormones and inflammation affect heart disease in women to better understand their unique risks and improve treatment.
-
Effects of Dapagliflozin on Heart Health in Patients with Acute Coronary Syndromes
This study is testing if dapagliflozin, a diabetes medication, can improve heart health in people who have just had a heart attack.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.